Real-world use of ivacaftor in Canada: A retrospective analysis using the Canadian Cystic Fibrosis Registry
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health
Reference32 articles.
1. Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation;Flume;Chest,2012
2. Sustained benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data;Sawicki;Am. J. Respir. Crit. Care Med.,2015
3. Tezacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del;Taylor-Cousar;New Engl. J. Med.,2017
4. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;New Engl. J. Med.,2011
5. Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST);McKone;Lancet Respir. Med.,2014
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy;Respiratory Research;2024-04-27
2. Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis;International Journal of Infectious Diseases;2024-02
3. Medication use in people with cystic fibrosis before and after modulator therapy;Pulmonary Pharmacology & Therapeutics;2023-12
4. Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations;Annals of the American Thoracic Society;2023-07-01
5. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist;Journal of Clinical Investigation;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3